| NAME |
DIDANOSINE 200MG CAP,EC |
| VA GENERIC NAME |
DIDANOSINE |
| DOSAGE FORM |
CAP,EC |
| FDA MED GUIDE |
Didanosine_EC_(Generic)_(2018).pdf |
| FORMULARY DESIGNATOR |
PA-F |
| FORMULARY DESIGNATOR TEXT |
Restricted to HIV/ID (or facility designated/authorized provider)
|
| ACTIVE INGREDIENTS |
|
| NATIONAL FORMULARY INDICATOR |
YES |
| CS FEDERAL SCHEDULE |
Unscheduled |
| STRENGTH |
200 |
| SINGLE/MULTI SOURCE PRODUCT |
Multisource |
| INACTIVATION DATE |
2020-07-15 00:00:00 |
| UNITS |
MG |
| NATIONAL FORMULARY NAME |
DIDANOSINE CAP,EC |
| CREATE DEFAULT POSSIBLE DOSAGE |
YES |
| CODING SYSTEM |
|
| COPAY TIER |
-
- COPAY TIER LEVEL: 2
- COPAY EFFECTIVE DATE: 2017-02-27 00:00:00
|
| PGX ELIGIBLE |
NO |
| PGX SUPPRESSED |
NO |
| VA PRINT NAME |
DIDANOSINE 200MG EC CAP |
| VA PRODUCT IDENTIFIER |
D0629 |
| TRANSMIT TO CMOP |
YES |
| VA DISPENSE UNIT |
CAP |
| MASTER ENTRY FOR VUID |
YES |
| VUID |
4017030 |
| EFFECTIVE DATE/TIME |
-
- 2005-03-10 00:00:00
- STATUS: ACTIVE
-
- 2020-07-15 00:00:00
- STATUS: INACTIVE
|
